The US mail order pharmacy market analysis sheds light on the key factors enabling its growth; these include the increasing incidences of chronic diseases and surging adoption of mail order pharmacy services for different healthcare needs. Further, the integration of artificial intelligence (AI) in retail pharmacies is expected to emerge as a new trends in the market during 2022–2030. Based on drug type, the US mail order pharmacy market is bifurcated into non-prescription drugs and prescription drugs. The prescription drugs segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022–2030. The US mail order pharmacy market, by product, is segmented into dermal care products, anti-diabetic medicines, cardiovascular medicines, blood pressure medicines, asthma management products, cold & flu medicines, painkillers, antacids, and others. The dermal care products segment held the largest market share in 2022, and the cardiovascular medicines segment is anticipated to register the highest CAGR during 2022–2030. Based on the mode of order, the US mail order pharmacy market is categorized into online stores and pharmacy apps. The online store segment is expected to account for a maximum share of the market during 2022–2030.
Mail-order pharmacy makes it easy to manage medication ordering and refill using a computer or a smartphone. Medications are ordered by mail order pharmacy less expensive and can be covered in a health plan. The insurer can buy medications in large quantities directly from drug manufacturers at lower costs.
Chronic diseases such as diabetes, cardiovascular disorders, autoimmune disorders, and various cancer types are the leading causes of mortality worldwide. According to the National Association of Chronic Disease Directors 2022 report, nearly 40% of American adults have multiple chronic conditions (MCC). Additionally, the National Health Council report reveals that chronic conditions account for more than 75% of the total healthcare costs in the US. Heart disease, cancer, mental disorders, and pulmonary conditions rank among the 5 most expensive health conditions, based on total annual healthcare spending in the US. Similarly, diabetes is one of the life-threatening chronic diseases with no functional cure. All types of diabetes may lead to complications in different body parts and trigger the overall risk of premature death. According to a report published by the Centers for Disease Control and Prevention (CDC), a total of 37.3 million people in the US (i.e., 11.3% of the US population) suffer from diabetes every year, including 8.5 million (23.0% of adults) undiagnosed cases and 28.7 million (28.5 million adults) diagnosed cases. Medication adherence among chronic disease patients can offer better health outcomes, with a reduction in hospitalizations and costs. Non-adherence to inhaled corticosteroids is responsible for ~24% of asthma exacerbations. There have been many attempts to increase medication adherence and improve patient care in the US. Various insurance companies provide financial incentives to encourage customers to fill prescriptions via mail-order pharmacies, which proves less expensive for patients. Mail-order pharmacy services are typically offered for buying drugs prescribed for chronic conditions such as high cholesterol, asthma, high blood pressure, diabetes, and depression. Through this pharmacy model, customers can receive medicines for 90 days rather than getting prescriptions refilled every month. Therefore, in addition to the increasing incidences of chronic diseases—medication nonadherence, population aging, and convenience over traditional methods drive growth of the US mail order pharmacy market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 43.728.62 Million |
Market Size by 2030 | US$ 1,71,883.03 Million |
Global CAGR (2022 - 2030) | 18.66% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By Drug Type
|
Regions and Countries Covered | United State
|
Market leaders and key company profiles |
The List of Companies - US Mail Order Pharmacy Market
Key factors that are driving the growth of this market are increasing incidences of chronic diseases and increasing adoption of mail order pharmacy services for specific healthcare needs to boost the market growth for the US Mail-Order Pharmacy over the years.
Prescription medicine segment held the largest share of the market in the US mail-order pharmacy and held the largest market share in 2022.
Mail-order pharmacy makes it easy to manage medication ordering and refill using a computer or a smartphone. Medications are ordered by mail order pharmacy less expensive and are operated through health plan. The insurer can buy medications in large quantities directly from drug manufacturers to lower costs.
The CAGR value of the US Mail-Order Pharmacy during the forecasted period of 2023-2028 is 18.66%.
CVS Health Corp and GeniusRx are the top two companies that hold huge market shares in the US mail-order pharmacy.
The dermal care segment dominated the US mail-order pharmacy and held the largest market share in 2022.
The US mail-order pharmacy majorly consists of the players such CVS Health Corp, Walmart Inc, Envirotainer AB, Able Freight Services LLC, Deutsche Post AG, GeniusRx, Geisinger Health, Cornerstone Health Solutions LLC, Humana Inc, Ridgeway Pharmacy LLC, and The Cigna Group, and among others. .